Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1977 1
1980 1
1981 1
1982 2
1983 5
1984 2
1985 1
1986 1
1988 2
1991 2
1992 2
1993 1
1994 2
1995 4
1996 1
1997 1
1998 5
1999 3
2000 5
2001 2
2002 5
2003 2
2004 4
2005 5
2006 8
2007 10
2008 20
2009 13
2010 22
2011 13
2012 18
2013 22
2014 30
2015 36
2016 37
2017 20
2018 31
2019 31
2020 29
2021 35
2022 20
2023 18
2024 30
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Results by year

Filters applied: . Clear all
Page 1
Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.
Miao X, Wu LS, Lin SXW, Xu Y, Chen Y, Iwaki Y, Kobos R, Stephenson T, Kemmerer K, Uhlar CM, Banerjee A, Goldberg JD, Trancucci D, Apte A, Verona R, Pei L, Desai R, Hickey K, Su Y, Ouellet D, Samtani MN, Guo Y, Garfall AL, Krishnan A, Usmani SZ, Zhou H, Girgis S. Miao X, et al. Among authors: wu ls. Target Oncol. 2023 Sep;18(5):667-684. doi: 10.1007/s11523-023-00989-z. Epub 2023 Sep 15. Target Oncol. 2023. PMID: 37713090 Free PMC article.
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study.
Cortes-Selva D, Perova T, Skerget S, Vishwamitra D, Stein S, Boominathan R, Lau O, Calara-Nielsen K, Davis C, Patel J, Banerjee A, Stephenson T, Uhlar C, Kobos R, Goldberg J, Pei L, Trancucci D, Girgis S, Wang Lin SX, Wu LS, Moreau P, Usmani SZ, Bahlis NJ, van de Donk NWCJ, Verona RI. Cortes-Selva D, et al. Among authors: wu ls. Blood. 2024 Aug 8;144(6):615-628. doi: 10.1182/blood.2023022823. Blood. 2024. PMID: 38657201 Free PMC article. Clinical Trial.
Vitamin D receptor gene polymorphisms in atopy.
Tamasauskiene L, Golubickaite I, Ugenskiene R, Sjakste N, Paramonova N, Wu LS, Wang LS, Sitkauskiene B. Tamasauskiene L, et al. Among authors: wu ls. Immun Inflamm Dis. 2021 Dec;9(4):1153-1159. doi: 10.1002/iid3.487. Epub 2021 Aug 3. Immun Inflamm Dis. 2021. PMID: 34343413 Free PMC article. Review.
Acupuncture for general veterinary practice.
Chan WW, Chen KY, Liu H, Wu LS, Lin JH. Chan WW, et al. Among authors: wu ls. J Vet Med Sci. 2001 Oct;63(10):1057-62. doi: 10.1292/jvms.63.1057. J Vet Med Sci. 2001. PMID: 11714019 Free article. Review.
COVID-19 and asthma, the good or the bad?
Wang JY, Pawankar R, Tsai HJ, Wu LS, Kuo WS. Wang JY, et al. Among authors: wu ls. Allergy. 2021 Feb;76(2):565-567. doi: 10.1111/all.14480. Epub 2020 Jul 20. Allergy. 2021. PMID: 32621304 Free PMC article. No abstract available.
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.
Willemin ME, Wang Lin SX, De Zwart L, Wu LS, Miao X, Verona R, Banerjee A, Liu B, Kobos R, Qi M, Ouellet D, Goldberg JD, Girgis S. Willemin ME, et al. Among authors: wu ls. CPT Pharmacometrics Syst Pharmacol. 2024 Jul;13(7):1117-1129. doi: 10.1002/psp4.13144. Epub 2024 Jun 3. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38831634 Free PMC article.
457 results